{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T20:49:12Z","timestamp":1766868552037,"version":"3.28.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.cld.2024.03.011","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T12:28:01Z","timestamp":1716380881000},"page":"503-523","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Renal Complications in Portal Hypertension"],"prefix":"10.1016","volume":"28","author":[{"given":"Adri\u00e0","family":"Juanola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Thu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Gratac\u00f3s-Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Pose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2024.03.011_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis \u2014 aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib3","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2024.03.011_bib4","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.kint.2021.02.037","article-title":"Hepatorenal syndrome: a historical appraisal of its origins and conceptual evolution","volume":"99","author":"Eknoyan","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.cld.2024.03.011_bib5","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cld.2024.03.011_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.03.011_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the acute kidney injury network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A\u00a0modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib10","doi-asserted-by":"crossref","first-page":"e0160394","DOI":"10.1371\/journal.pone.0160394","article-title":"Relevance of new definitions to incidence and prognosis of acute kidney injury in hospitalized patients with cirrhosis: a retrospective population-based cohort study","volume":"11","author":"Tandon","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2024.03.011_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.04.043","article-title":"Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis \u2013 a US population-based study","author":"Desai","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.14309\/ajg.0000000000000670","article-title":"Hospital-acquired versus community-acquired acute kidney injury in patients with cirrhosis: a prospective study","volume":"115","author":"Patidar","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2024.03.011_bib13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib14","doi-asserted-by":"crossref","first-page":"101822","DOI":"10.1016\/j.clinre.2021.101822","article-title":"Acute kidney injury in patients with cirrhosis: prospective longitudinal study in 405 patients","volume":"46","author":"Moga","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cld.2024.03.011_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/MEG.0000000000001947","article-title":"The impact of acute kidney injury on mortality and clinical outcomes in patients with alcoholic cirrhosis in the USA","volume":"33","author":"Makar","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.07.010","article-title":"Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US","author":"Patidar","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/108139","article-title":"Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: a prospective cohort study","volume":"2015","author":"Allegretti","year":"2015","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.cld.2024.03.011_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Mart\u00edn\u2013Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.03.011_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12072-016-9706-9","article-title":"National trends of acute kidney injury requiring dialysis in decompensated cirrhosis hospitalizations in the United States","volume":"10","author":"Nadkarni","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cld.2024.03.011_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MEG.0000000000002520","article-title":"Acute kidney injury development and impact on clinical and economic outcomes in patients with cirrhosis: an observational cohort study over a 10-year period","volume":"35","author":"Alshogran","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib23","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.cld.2024.03.011_bib24","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/liv.12852","article-title":"New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine?","volume":"35","author":"Rosi","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2024.03.011_bib25","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","author":"Angeli","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib26","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the american association for the study of liver diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000241","article-title":"Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: a US nationwide study","author":"Patidar","year":"2023","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2024.03.011_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cld.2024.03.011_bib29","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2024.03.011_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2215289","article-title":"Acute kidney injury in patients with cirrhosis","volume":"388","author":"Nadim","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.03.011_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib32","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000359","article-title":"Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study","volume":"12","author":"Allegretti","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cld.2024.03.011_bib33","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/hep.32799","article-title":"Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury","volume":"77","author":"Gambino","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15198","article-title":"Assessment of glomerular filtration rate in patients with cirrhosis: available tools and perspectives","author":"Campion","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2024.03.011_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1055\/a-1954-4136","article-title":"Novel biomarkers of AKI in cirrhosis","volume":"42","author":"Juanola","year":"2022","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2024.03.011_bib36","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/lt.26216","article-title":"Estimating glomerular filtration rate in cirrhosis using creatinine-based and cystatin c\u2013based equations: systematic review and meta-analysis","volume":"27","author":"Singapura","year":"2021","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2024.03.011_bib37","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.29290","article-title":"Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis","volume":"66","author":"Markwardt","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib38","article-title":"Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis","author":"Juanola","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.cld.2024.03.011_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib40","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1515\/CCLM.2011.156","article-title":"Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia","volume":"49","author":"Decavele","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cld.2024.03.011_bib42","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","article-title":"Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis","volume":"15","author":"Puthumana","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/liv.15096","article-title":"Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury","volume":"42","author":"Patidar","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2024.03.011_bib44","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/liv.13239","article-title":"Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis","volume":"37","author":"Fern\u00e1ndez","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2024.03.011_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.03.011_bib47","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gines","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.03.011_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.03.011_bib49","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.03.011_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib51","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.14309\/00000434-201210001-00418","article-title":"Role of terlipressin and albumin combination versus albumin alone in hepatorenal syndrome","volume":"107","author":"Zafar","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2024.03.011_bib52","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib53","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type i hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2024.03.011_bib54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib55","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn\u2013Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.03.011_bib56","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Prashant","year":"2003","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib57","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.03.011_bib58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib59","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.03.011_bib60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib61","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011532.pub2","article-title":"Terlipressin versus other vasoactive drugs for hepatorenal syndrome","author":"Israelsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2024.03.011_bib63","doi-asserted-by":"crossref","first-page":"e0890","DOI":"10.1097\/CCE.0000000000000890","article-title":"Role of terlipressin in patients with hepatorenal syndrome-acute kidney injury admitted to the ICU: a substudy of the confirm trial","volume":"5","author":"Karvellas","year":"2023","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.cld.2024.03.011_bib64","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.34067\/KID.0000000000000132","article-title":"The effect of terlipressin on renal replacement therapy in patients with hepatorenal syndrome","volume":"4","author":"Velez","year":"2023","journal-title":"Kidney360"},{"key":"10.1016\/j.cld.2024.03.011_bib65","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/hep.31529","article-title":"Response to Terlipressin and albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome","volume":"73","author":"Piano","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib66","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib67","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/apt.17195","article-title":"Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure","volume":"56","author":"Wong","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2024.03.011_bib68","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib69","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cld.2024.03.011_bib70","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2024.03.011_bib71","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","article-title":"The evaluation of renal function and disease in patients with cirrhosis","volume":"52","author":"Francoz","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib72","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2024.03.011_bib73","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib74","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/lt.25694","article-title":"Chronic kidney disease in liver transplant candidates: a rising burden impacting post\u2013liver transplant outcomes","volume":"26","author":"Cullaro","year":"2020","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2024.03.011_bib75","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/lt.25454","article-title":"Impact of chronic kidney disease on outcomes in cirrhosis","volume":"25","author":"Wong","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2024.03.011_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","author":"Devarbhavi","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib77","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2019.12.020","article-title":"Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes","volume":"72","author":"Bassegoda","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib78","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hep.30859","article-title":"Incidence, risk factors, and outcomes of transition of acute kidney injury to chronic kidney disease in cirrhosis: a prospective cohort study","volume":"71","author":"Maiwall","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib79","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.03.011_bib80","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.011_bib81","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib82","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2021.04.010","article-title":"Peritoneal dialysis use in patients with ascites: a review","volume":"78","author":"Rajora","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cld.2024.03.011_bib83","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/tri.13388","article-title":"Simultaneous liver kidney transplantation","volume":"32","author":"Singal","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.cld.2024.03.011_bib84","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2023.04.028","article-title":"TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis","volume":"79","author":"Larrue","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib85","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.dld.2021.09.008","article-title":"Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: impact on renal function","volume":"54","author":"Ponzo","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2024.03.011_bib86","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/lt.24210","article-title":"Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: effects on kidney function and transplantation outcomes","volume":"21","author":"Rodriguez","year":"2015","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2024.03.011_bib87","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2024.03.011_bib88","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib89","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cld.2024.03.011_bib90","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cld.2024.03.011_bib91","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib92","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/dc15-1182","article-title":"Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities","volume":"39","author":"Musso","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cld.2024.03.011_bib93","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molmed.2015.08.005","article-title":"Emerging liver\u2013kidney interactions in nonalcoholic fatty liver disease","volume":"21","author":"Musso","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cld.2024.03.011_bib94","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nrgastro.2012.79","article-title":"Increased risk of cardiovascular disease and chronic kidney disease in NAFLD","volume":"9","author":"Bonora","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2024.03.011_bib95","doi-asserted-by":"crossref","first-page":"E606","DOI":"10.1111\/j.1399-0012.2011.01497.x","article-title":"Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more","volume":"25","author":"Park","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cld.2024.03.011_bib96","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/TP.0000000000000945","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States","volume":"100","author":"Singal","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2024.03.011_bib97","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/liv.12381","article-title":"The impact of gender and NASH on chronic kidney disease before and after liver transplantation","volume":"34","author":"Fussner","year":"2014","journal-title":"Liver Int"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T17:59:06Z","timestamp":1732039146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1089326124000369"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.03.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Complications in Portal Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}